| 5.07 0.11 (2.22%) | 09-13 11:51 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 8.34 | 1-year : | 9.98 |
| Resists | First : | 7.14 | Second : | 8.55 |
| Pivot price | 6.01  |
|||
| Supports | First : | 4.87 | Second : | 4.05 |
| MAs | MA(5) : | 5.18 |
MA(20) : | 6.32 |
| MA(100) : | 7.25 |
MA(250) : | 8.36 |
|
| MACD | MACD : | -0.7 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 7.9 |
D(3) : | 7.4 |
| RSI | RSI(14): 33.2 |
|||
| 52-week | High : | 26.7 | Low : | 3.79 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ CCM ] has closed above bottom band by 17.4%. Bollinger Bands are 45.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 26 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 5.39 - 5.43 | 5.43 - 5.46 |
| Low: | 4.99 - 5.03 | 5.03 - 5.06 |
| Close: | 5.02 - 5.08 | 5.08 - 5.13 |
Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
Sun, 01 Sep 2024
Positive Sentiment Still Eludes Concord Medical Services Holdings Limited (NYSE:CCM) Following 26% Share Price Slump - Simply Wall St
Wed, 07 Aug 2024
Concord Medical Regains Compliance with NYSE Minimum Price Requirement - StockTitan
Wed, 31 Jul 2024
Concord Medical Services Holdings (NYSE:CCM investor three-year losses grow to 79% as the stock sheds US$48m this past week - Yahoo Finance
Mon, 29 Jul 2024
Upcoming Stock Splits This Week (July 29 to August 2) – Stay Invested - Yahoo Finance
Thu, 11 Jul 2024
Concord Medical Announces Reverse ADS Split - TipRanks
Thu, 11 Jul 2024
Concord Medical announces ADS ratio adjustment - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 3 (M) |
| Shares Float | 42 (M) |
| Held by Insiders | 18 (%) |
| Held by Institutions | 0.2 (%) |
| Shares Short | 16 (K) |
| Shares Short P.Month | 27 (K) |
| EPS | -9.57 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -488.74 |
| Profit Margin | -55.4 % |
| Operating Margin | -98.5 % |
| Return on Assets (ttm) | -4.9 % |
| Return on Equity (ttm) | -28.3 % |
| Qtrly Rev. Growth | -22.9 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 190.56 |
| EBITDA (p.s.) | -122.05 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -276 (M) |
| Levered Free Cash Flow | -52 (M) |
| PE Ratio | -0.54 |
| PEG Ratio | 0 |
| Price to Book value | -0.02 |
| Price to Sales | 0.02 |
| Price to Cash Flow | -0.06 |
| Dividend | 9.89 |
| Forward Dividend | 0 |
| Dividend Yield | 195.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|